#Sweden #Stockholm #Women's Health #Lactiplantibacillus #Probi AB

Biotic Innovation Tackles Iron Deficiency in Women

Introduction
Iron deficiency is a global health issue affecting over 30% of women of reproductive age. With the aim of combatting this pressing nutritional challenge, Probi AB has introduced a revolutionary health solution that enhances iron absorption specifically for women.

International Recognition
Recently, this innovative product has been acknowledged on three continents – Europe, North America, and Asia, marking a significant milestone for Probi. The recognition culminated in the 2025 NutraIngredients-Asia Award for Innovation in Women's Health, cementing the product’s role in addressing the urgent need for better iron supplementation. Speaking about this success, Martina Pettersson, Global Marketing Director of Probi, stated, "Recognition across three continents in a single year speaks to the urgent, global nature of this issue and to the promise of science-backed, biotic innovations in addressing it."

How It Works
The key behind this biotic solution is a clinically studied probiotic strain known as Lactiplantibacillus plantarum 299v (LP299V®). Unlike traditional iron supplements that can lead to gastrointestinal discomfort, LP299V® facilitates improved iron absorption by ensuring that iron remains in a form that the body can easily utilize. Additionally, it helps increase the expression of iron-converting enzymes in the body, resulting in enhanced absorption from food and supplements.

The Science Behind the Solution
Probi’s patented strain works effectively by two mechanisms: first, it helps maintain iron in its absorbable form, and second, it boosts the body's natural processes to convert and utilize iron more efficiently. The result is a significant reduction in the side effects typically associated with conventional iron supplements, thus making this innovation a highly tolerable option for women.

Global Implications
The impact of this biotic innovation is profound, especially in Asian markets where iron deficiency continues to pose health challenges for millions of women. As remarked by Karen Ong, Head of Asia-Pacific at Probi, "This innovation has a critical role to play in Asia, where iron deficiency continues to impact millions of women. This reinforces how accessible and well-tolerated solutions can make a meaningful difference."

Probi's Commitment to Women's Health
Founded in 1991, Probi has consistently aimed to enhance women's health through innovative probiotics. Initially gaining recognition for digestive benefits, the company is now broadening its focus to support better health outcomes related to iron deficiency. LP299V® has been the subject of extensive research for over three decades, underlining Probi's commitment to delivering scientifically backed health solutions.

Conclusion
As the global demand for effective iron supplementation rises, Probi's biotic innovation stands out not just as a solution for iron deficiency but also as a testament to the importance of scientific research in health advancement. With awards and recognitions paving the way for more awareness, it is evident that solutions like LP299V® could reshape women’s health on a global scale.

About Probi
Probi® is a renowned biotics solutions company dedicated to researching, manufacturing, and delivering probiotics for supplements and functional foods. With a commitment to enhancing quality of life through gut health, Probi operates in over 40 markets worldwide and has been part of Symrise AG since 2025, which bolsters its innovation and outreach capacity.